CD8A and neoplasm: By combining the PEI/CpG/OVA nano-vaccine with HAase, the infiltration of antigen-specific CD8 + T cells generated by the vaccine in tumor tissues has significantly enhanced the efficacy of in vivo anti-tumor immunotherapy.